Zobrazeno 1 - 9
of 9
pro vyhledávání: '"KE-TAO JIN"'
Autor:
Huan-Rong Lan, You-Ni Zhang, Yue-Jun Han, Shi-Ya Yao, Meng-Xiang Yang, Xiao-Gang Xu, Xiao-Zhou Mou, Ke-Tao Jin
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract Lymph node metastasis is a frequent occurrence in a variety of tumour forms and poses an enormous challenge to cancer treatment. This process is critical to the development of the disease and is frequently linked to a poor prognosis. Over 90
Externí odkaz:
https://doaj.org/article/b73305f658ea4f7cae7ef34eb9702c44
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Breast cancer (BCa) is known as a complex and prevalent disease requiring the development of novel anticancer therapeutic approaches. Bispecific antibodies (BsAbs) have emerged as a favorable strategy for BCa treatment due to their unique ability to
Externí odkaz:
https://doaj.org/article/7d43cc4bf6354ff2be5fb46f78ca574e
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-15 (2021)
Abstract Colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer deaths worldwide. Besides common therapeutic approaches, such as surgery, chemotherapy, and radiotherapy, novel therapeutic approaches, including
Externí odkaz:
https://doaj.org/article/479eaa31706a495d807405bd2b98021a
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Cancer immunotherapy is exploited for the treatment of disease by modulating the immune system. Since the conventional in vivo animal and 2D in vitro models insufficiently recapitulate the complex tumor immune microenvironment (TIME) of the original
Externí odkaz:
https://doaj.org/article/aeb895aad2f741a5b768b9dd810a5299
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Colorectal cancer (CRC) is the second leading cause of cancer death in the world. Immunotherapy using monoclonal antibodies, immune-checkpoint inhibitors, adoptive cell therapy, and cancer vaccines has raised great hopes for treating poor prognosis m
Externí odkaz:
https://doaj.org/article/651160a5315c4b32923bdb3a175e02ed
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 134, Iss, Pp 110932-(2021)
Oncolytic viruses have attracted attention as a promising strategy in cancer therapy owing to their ability to selectively infect and kill tumor cells, without affecting healthy cells. They also exert their anti-tumor effects by releasing immunostimu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31da20f6e25e82a7e6bdbe4f91f8cf1e
http://www.sciencedirect.com/science/article/pii/S0753332220311240
http://www.sciencedirect.com/science/article/pii/S0753332220311240
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 9(4)
Radiofrequency ablation (RFA) is a minimally invasive surgical procedure which has widespread popularity in the treatment of hepatic and pancreatic cancers. Increased evidence indicates that RFA stimulates anti-tumor immunity, possibly through the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::68f8815c9b1bd9dde4aae951fbf2a0ab
https://pubmed.ncbi.nlm.nih.gov/20688598
https://pubmed.ncbi.nlm.nih.gov/20688598
Autor:
Xiao-Yi Chen, Guo-Qing Ru, Ying-Yu Ma, Jun Xie, Wan-Yuan Chen, Hui-Ju Wang, Shi-Bing Wang, Li Li, Ke-Tao Jin, Xiang-Lei He, Xiao-Zhou Mou
Publikováno v:
OncoTargets & Therapy; Jun2016, Vol. 9, p3595-3602, 8p
Autor:
XIN XU, LI-JUAN QIAN, XING-YUN SU, KUI-FENG HE, KE-TAO JIN, LIN-HUI GU, JIAN-GUO FENG, GUANG-LIANG LI, QUAN ZHOU, ZHEN-ZHEN XU, HAO-HAO WANG, JING ZHANG, JIANG CAO, LI-SONG TENG
Publikováno v:
International Journal of Oncology; 2015, Vol. 46 Issue 6, p2479-2487, 9p